Pre-treatment EGFR mutation analysis predicts clinical outcome in a retrospective analysis of 24 non-squamous non-small-cell lung cancer (NSCLC) patients treated with second line afatinib.

被引：0
|
作者：
van der Wekken, Anthonie J. [1 ]
Kuiper, Justine L. [2 ]
Heideman, Danielle A. M. [2 ]
Schuuring, Ed [1 ]
Timens, Wim [1 ]
Thunnissen, Erik [2 ]
Groen, Harry J. M. [1 ]
Smit, Egbert F. [2 ]
机构：
[1] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3526
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETROSPECTIVE EFFICACY AND SAFETY ANALYSIS OF ERLOTINIB (E), PEMETREXED (P) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SQUAMOUS AND NON-SMALL-CELL LUNG CANCER PATIENTS (NSCLC) WITHOUT EGFR MUTATION
    Takeshita, Jumpei
    Katakami, Nobuyuki
    Nishiyama, Akihiro
    Yoshioka, Hiroshige
    Iwasaku, Masahiro
    Otsuka, Kojiro
    Imamura, Fumio
    Nishino, Kazumi
    Yokota, Soichiro
    Morita, Satoshi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
  • [2] PHARMACOGENETIC STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Yasue, T.
    Hirashima, T.
    Kobayashi, M.
    Okamoto, N.
    Suzuki, H.
    Hosono, K.
    Morishita, N.
    Matsuura, Y.
    Tamiya, M.
    Shiroyama, T.
    Morita, S.
    Matsumoto, T.
    Morishita, H.
    Kawahara, K.
    Kawase, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 136 - 136
  • [3] Regional retrospective analysis of outcomes of EGFR mutated non-squamous non-small cell lung cancer (NSCLC) patients in West Yorkshire
    Sharma, D.
    Slevin, F.
    Clarke, K.
    Franks, K.
    Snee, M.
    Jain, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] EFFICACY AND SAFETY OF PEMETREXED AS SECOND-LINE TREATMENT IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE ANALYSIS
    Passaro, A.
    Pochesci, A.
    Palleschi, M.
    Pellegrino, A.
    Fabbri, M. A.
    Urbano, F.
    Gentile, V.
    Manai, C.
    Pavese, I.
    Cortesi, E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [5] RETROSPECTIVE ANALYSIS OF TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH ADVANCED AND RECURRENT NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER IN OUR INSTITUTE
    Yoshino, R.
    Tomizawa, Y.
    Miura, Y.
    Nishioka, M.
    Yoshii, A.
    Watanabe, S.
    Saitou, R.
    Mori, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 135 - 135
  • [6] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [7] Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer
    Marrett, Elizabeth
    Kwong, Winghan Jacqueline
    Chow, Laura Q. M.
    FUTURE ONCOLOGY, 2022, 18 (13) : 1535 - 1544
  • [8] Retrospective analysis of a group of patients with advanced Non-Small-Cell lung cancer (NSCLC) treated with Gefitinib
    Bandera, M.
    Bascialla, L.
    Martinelli, B.
    Masera, G. L. Rodolfo
    Vallini, I.
    Zanlorenzi, L.
    Pinotti, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 25 - 25
  • [9] Pemetrexed (PEM) Plus Platinum-based Regimen as First Line Treatment in Unselected Patients Affected With Non-squamous Non-small-cell Lung Cancer (NSCLC): a Retrospective Multicenter Analysis
    Moscetti, L.
    Fabbri, M. A.
    Narducci, F.
    Mansueto, G.
    Longo, F.
    Martelli, O.
    Angelini, F.
    Pavese, I.
    Ruggeri, E. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S617 - S617
  • [10] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian, Yaru
    Tian, Hairong
    Zhai, Xiaoyang
    Zhu, Hui
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2022, 16 (04) : 610 - 617
12345